BioCentury This Week

BioCentury This Week

Por: BioCentury
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
352 episodios disponibles

Latest episodes of the podcast BioCentury This Week

Mostrando página 12 de 18

Ep. 129 - Burr Bill, Novartis Makeover, ALS Update 18/07/2022
Ep. 128 - Financial Markets Forecast, AAV Toxicity & Drug Pricing 11/07/2022
Ep. 127 - TeneoTwo, Lightspeed, Arch & The Distillery 05/07/2022
Ep. 126 - Growing Galapagos, Plus Abortion & Biopharma 27/06/2022
Ep. 125 - Next Steps for ARPA-H 20/06/2022
Ep. 124 - CRISPR's High Bar, Private Equity Inroads and the Distillery 13/06/2022
Ep. 123 - Fixing FDA's Broken Advisory Panels 08/06/2022
Ep. 122 - ASCO's Advances & Fixes for FDA's AdComms 06/06/2022
Ep. 121 - ASCO, CRISPR IP & CStone 31/05/2022
Ep. 120 - Next-gen NK cells, Plus Woodcock & BMS’s Russian Withdrawal 23/05/2022
Ep. 119 - Bio€quity Recap, Part 2 18/05/2022
Ep. 118 - Bio€quity Recap, Part 1 17/05/2022
Ep. 117 - Sofinnova Partners’ Growth Deal, Plus Distillery on Tap 16/05/2022
Ep. 116 - The Road to Bio€quity 2022: Navigating Through Talent & Capital Headwinds 12/05/2022
Ep. 115 - FDA Reform on Deck, Plus Translation at Howard 09/05/2022
Ep. 114 - Hutchmed Setback, FDA in Focus, HilleVax's IPO 02/05/2022
Ep. 113 - Nkarta’s Breakthrough, Hatch’s Legacy & Shanghai’s Lockdown 25/04/2022
Ep. 112 - Digesting DDR Data; Plus Sharpless’ Legacy, McKinsey’s Conflicts 18/04/2022
Ep. 111 - Seeking Green Shoots Amid Biotech’s Gloom 14/04/2022
Ep. 110 - Aduhelm’s Lessons, Plus Distillery Discoveries, Rare Disease Innovation 11/04/2022
« Primera ‹ Anterior 1 ... 10 11 12 13 14 ... 18 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA